Key result
Reevaluation of genetic variants of unknown significance in young sudden unexplained death cases after 5 years led to the reclassification of 10.5% of variants to benign or likely benign.
Why the study?
Over 80% of rare variants in sudden unexplained death cases remain classified as having an ambiguous role, impeding clinical translation.
Does periodic reevaluation of ambiguous genetic variants using updated population frequencies improve variant classification in young cases of sudden unexplained death?
Observational (n=51)
No
Does periodic reevaluation of ambiguous genetic variants using updated population frequencies improve variant classification in young cases of sudden unexplained death?
Periodic reevaluation of ambiguous genetic variants in sudden unexplained death cases every 5 years is crucial, as updated population frequencies can downgrade over 10% of VUS to benign/likely benign, aiding in genetic counseling and reducing anxiety for relatives.
Answers are grounded in this paper and cite their sources.
May warrant periodic VUS re-evaluation in sudden death cases; leaves open standardization of reclassification intervals and criteria.
Sudden death cases in the young population remain without a conclusive cause of decease in almost 40% of cases. In these situations, cardiac arrhythmia of genetic origin is suspected as the most plausible cause of death. Molecular autopsy may reveal a genetic defect in up to 20% of families. Most than 80% of rare variants remain classified with an ambiguous role, impeding a useful clinical translation. Our aim was to update rare variants originally classified as of unknown significance to clarify their role. Our cohort included fifty-one post-mortem samples of young cases who died suddenly and without a definite cause of death. Five years ago, molecular autopsy identified at least one rare genetic alteration classified then as ambiguous following the American College of Medical Genetics and Genomics' recommendations. We have reclassified the same rare variants including novel data. About 10% of ambiguous variants change to benign/likely benign mainly because of improved population frequencies. Excluding cases who died before one year of age, almost 21% of rare ambiguous variants change to benign/likely benign. This fact makes it important to discard these rare variants as a cause of sudden unexplained death, avoiding anxiety in relatives' carriers. Twenty-five percent of the remaining variants show a tendency to suspicious deleterious role, highlighting clinical follow-up of carriers. Periodical reclassification of rare variants originally classified as ambiguous is crucial, at least updating frequencies every 5 years. This action aids to increase accuracy to enable and conclude a cause of death as well as translation into the clinic.
No takes yet. Share an insight, caveat, or question.
Martinez-Barrios et al. (2023) conducted an observational in Sudden unexplained death in young population (SUDY) and sudden infant death syndrome (SIDS) (n=51). Reevaluation of genetic variants of unknown significance vs. Initial classification 5 years prior was evaluated on Reclassification of variants from unknown significance to benign or likely benign. Reevaluation of genetic variants of unknown significance in young sudden unexplained death cases after 5 years led to the reclassification of 10.5% of variants to benign or likely benign.
Synapse has enriched 10 related papers. Consider them for comparative context: